Idris Boudhabhay

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis

Idris Boudhabhay, Victoria Poillerat, Anne Grünenwald et al. · Kidney International · 2020 · 93 citations · Full text

Medicine, Immunology, Nephrology +16

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy

Lubka T. Roumenina, Philippe Chadebech, Gwellaouen Bodivit et al. · American Journal of Hematology · 2020 · 68 citations · Full text

Life Sciences, Hematology, Immunology +17

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome

Khalil El Karoui, Idris Boudhabhay, Florent Petitprez et al. · Haematologica · 2019 · 60 citations · Full text

Medicine, Hematology, Internal Medicine +17